Chapters 43 Definitions SLO 2.1 Flashcards
Antibiotic
Having the ability to destroy or interfere with the development of a living organism; most commonly refers to antibacterial drugs. (p. 692)
Antimicrobial stewardship
An institutional activity that includes ensuring appropriate selection, dosing, choice of route, and duration of antimicrobial therapy. (p. 695)
Antiseptic
One of two types of topical antimicrobial agents; a chemical that inhibits the growth and reproduction of microorganisms without necessarily killing them. Antiseptics are also called static agents. (p. 694)
Bactericidal antibiotics
that kill bacteria. (p. 698)
Bacteriostatic antibiotics
that do not kill bacteria but rather inhibit their growth. (p. 697)
Beta-lactam
A broad, major class of antibiotics that includes four subclasses: penicillins, cephalosporins, carbapenems, and monobactams, so named because of the beta-lactam ring that is part of the chemical structure of all drugs in this class. (p. 698)
Beta-lactamase
Any of a group of enzymes produced by bacteria that catalyze the chemical opening of the crucial beta-lactam ring structures in beta-lactam antibiotics. (p. 698)
Beta-lactamase inhibitors
Medications combined with certain penicillin drugs to block the effect of beta-lactamase enzymes. (p. 698)
Colonization
The establishment and growth of microorganisms on skin, open wounds, or mucous membranes or in secretions without causing an infection. (p. 693)
Community-acquired infection
An infection that is acquired by a person who has not recently been hospitalized or had a medical procedure (e.g., surgical procedure). (p. 693)
Targeted therapy
The administration of antibiotics based on known results of culture and sensitivity testing identifying the pathogen causing infection. (p. 694)
Disinfectant
One of two types of topical antimicrobial agents; a chemical applied to nonliving objects to kill microorganisms; also called cidal agents. (p. 694)
Empiric therapy
The administration of antibiotics based on the health care provider’s judgement of the pathogens most likely causing an apparent infection; It involves the presumptive treatment of an infection to avoid treatment delay, before specific culture information has been obtained. (p. 694)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
An inherited disorder in which red blood cells are partially or completely deficient in glucose-6-phosphate dehydrogenase, a crucial enzyme in the metabolism of glucose. (p. 696)
Health care–associated infection
An infection acquired during the course of receiving treatment for another condition in a health care facility. The infection is not present or incubating at the time of admission; also known as a nosocomial infection. (p. 693)
Host factors
that are unique to a particular patient that affect the patient’s susceptibility to infection and response to antibiotic drugs; examples include a low neutrophil count or a lack of immunoglobulins in the blood that carry antibodies. (p. 695)
Infections
Invasion and multiplication of microorganisms in body tissues. (p. 692)
Microorganisms
Microscopic living organisms; also called microbes. (p. 692)
Prophylactic antibiotic therapy
Antibiotics taken before anticipated exposure to an infectious organism in an effort to prevent the development of infection. (p. 694)
Pseudomembranous colitis
A potentially necrotizing inflammatory bowel condition that is often associated with antibiotic therapy; often caused by the bacterium Clostridium difficile; also called by the more general term
antibiotic-associated colitis. (p. 695)
Slow acetylation
A common genetic host factor in which the rate of metabolism of certain drugs is reduced. (p. 696)
Subtherapeutic
Generally refers to blood levels below therapeutic levels due to insufficient dosing. Also refers to antibiotic treatment that is ineffective in treating a given infection. Possible causes include inappropriate drug therapy, insufficient drug dosing, or bacterial drug resistance. (p. 695)
Superinfection
(1) An infection occurring during antimicrobial treatment for another infection, resulting from overgrowth of an organism not susceptible to the antibiotic used. (2) A secondary microbial infection that occurs in addition to an earlier primary infection, often because of weakening of the patient’s immune system function by the first infection. (p. 695)
Teratogens
Substances that can interfere with normal prenatal development and cause one or more developmental abnormalities in the fetus. (p. 696)